Clinical trial
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis
The primary purpose of this study is to identify an appropriate dose of study medication.
| Category | Value |
|---|---|
| Study start date | 2013-12-06 |